AMRN

Amarin Corporation PLC

Price

$13.68

return (12m)

-10.91%

p/e

-209.96

p/bv

12.84

DIVIDEND YIELD

0.00%

AMRN price

Amarin Corporation

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment AMRN

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-3.87%

3 months

-14.69%

1 year

-10.91%

2 years

15.87%

5 years

-86.67%

10 years

-74.68%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals AMRN

Valuation

P/E

-209.96

Sector -3.50

Industry -3.50

P/BV

12.84

Sector 2.02

Industry 2.02

P/Revenue (PSR)

30.58

Sector 2.01

Industry 2.01

EV/EBITDA

-474.74

Sector -214.99

Industry -214.99

EV/EBIT

-449.48

Sector -47.59

Industry -47.59

P/EBITDA

-131.84

Sector -21.41

Industry -21.41

P/EBIT

-123.70

Sector -28.65

Industry -28.65

P/Total Assets

9.12

Sector 1.19

Industry 1.19

P/Net Current Assets

13.49

Sector -11.97

Industry -11.97

P/Working Capital

12.99

Sector -167.95

Industry -167.95

EPS

-0.07

Sector -1.81

Industry -1.81

BVPS

1.07

Sector 2.06

Industry 2.06

Efficiency

Gross Margin

41.96%

Sector 41.30%

Industry 41.30%

EBITDA Margin

-26.85%

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

-28.36%

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

-21.89%

Sector -35.21%

Industry -35.21%

Net Profit Margins

-14.56%

Sector -35.91%

Industry -35.91%

Asset Turnover

0.07

Sector 0.02

Industry 0.02

Profitability

ROE

-6.11%

Sector -56.04%

Industry -56.04%

ROA

-4.34%

Sector -60.31%

Industry -60.31%

ROIC

-30.64%

Sector -2,335.95%

Industry -2,335.95%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

3.67

Sector 2.89

Industry 2.89

Net Debt / EBITDA

27.76

Sector -14,066,680.10

Industry -14,066,680.10

Net Debt / EBIT

26.29

Sector -8.06

Industry -8.06

Net Debt / Equity

-0.71

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

0.00

Sector -0.85

Industry -0.85

Equity/Assets

0.71

Sector 0.46

Industry 0.46

Liabilities/Assets

0.29

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

-20.41%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals AMRN

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
AMRN Amarin Corporation PLC	$13.68	-6.34%	0.00%	-209.96	12.84	-6.11%	-14.56%
JNJ Johnson & Johnson	$269.33	55.44%	1.96%	30.82	7.63	24.76%	21.48%
PFE Pfizer Inc.	$27.49	22.33%	6.26%	35.85	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$263.93	23.34%	2.59%	73.99	-78.76	-106.44%	9.81%
NVO Novo Nordisk A/S	$43.19	-26.70%	4.29%	10.56	5.61	53.11%	35.32%
MRK Merck & Co. Inc.	$146.11	87.14%	2.31%	113.21	8.55	7.55%	4.76%
AZN AstraZeneca PLC	$166.35	9.78%	1.94%	19.88	5.12	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$62.71	43.77%	4.04%	13.67	5.68	41.55%	18.85%
ZTS Zoetis Inc.	$72.66	-49.60%	2.88%	11.47	9.64	84.02%	27.77%
AMGN Amgen Inc.	$383.04	43.28%	2.60%	23.66	17.70	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$784.44	31.54%	0.47%	18.63	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$111.35	46.87%	0.00%	31.57	90.97	288.13%	24.86%
MCK McKesson Corporation	$874.67	27.00%	0.38%	19.57	-26.84	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$506.08	30.72%	0.00%	29.15	6.34	21.76%	35.00%
CAH Cardinal Health Inc.	$224.45	52.89%	0.91%	30.53	-19.32	-63.29%	0.68%
ARGX argenx SE	$994.44	35.42%	0.00%	2.24	2.63	117.11%	44.68%
HRMY Harmony Biosciences Holdings Inc.	$42.23	31.71%	0.00%	13.50	2.45	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

AMRN Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Amarin Corporation

Amarin Corporation PLC

Average Investor10 user rating

4.0 (2 people)

United States

37 years

Founded: 1989

1993

Time since IPO - 33 years

1.000

Employees

Amarin Corporation PLC (United States) is listed on the Nasdaq and has a market capitalization of $5.69 billion, with shareholders equity totaling $443.62 million.

The company employs approximately 1.000 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Amarin Corporation PLC reported $186.23 million in revenue, generating net income of $-27.12 million.

Key financial metrics include a P/E ratio of -209.96, a price-to-book (P/B) ratio of 12.84, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker AMRN.

Market cap

$5.69 billion

Net worth

$443.62 million

$443,616,000.00

Assets

$624.36 million

$624,363,000.00

Total Shares Outstanding

416.44 million

416,444,000

Average Daily Trading Volume

$66.69 Thousand

$66,688.46

Sector

Health Care

Industry

Biotechnology

AMRN

AMRN revenue and profits

Financial Results AMRN

DRAG THE FRAME TO SEE MORE DATA

AMRN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$874.67 25,76% (12M)

P/E

19.57

0.38%

ROE

-137.16%

P/BV

-26.84

CAH - Cardinal Health

$224.45 51,61% (12M)

P/E

30.53

0.91%

ROE

-63.29%

P/BV

-19.32

JNJ - Johnson & Johnson

$269.33 56,33% (12M)

P/E

30.82

1.96%

ROE

24.76%

P/BV

7.63

ABBV - AbbVie

$263.93 22,42% (12M)

P/E

73.99

2.59%

ROE

-106.44%

P/BV

-78.76

MRK - Merck & Co.

$146.11 85,19% (12M)

P/E

113.21

2.31%

ROE

7.55%

P/BV

8.55

AZN - AstraZeneca

$166.35 9,17% (12M)

P/E

19.88

1.94%

ROE

25.77%

P/BV

5.12

PFE - Pfizer

$27.49 22,43% (12M)

P/E

35.85

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$874.67 25,76% (12 M)

P/L

19.57

0.38%

ROE

-137.16%

P/VP

-26.84

CAH - Cardinal Health

$224.45 51,61% (12 M)

P/L

30.53

0.91%

ROE

-63.29%

P/VP

-19.32

JNJ - Johnson & Johnson

$269.33 56,33% (12 M)

P/L

30.82

1.96%

ROE

24.76%

P/VP

7.63

ABBV - AbbVie

$263.93 22,42% (12 M)

P/L

73.99

2.59%

ROE

-106.44%

P/VP

-78.76

MRK - Merck & Co.

$146.11 85,19% (12 M)

P/L

113.21

2.31%

ROE

7.55%

P/VP

8.55

AZN - AstraZeneca

$166.35 9,17% (12 M)

P/L

19.88

1.94%

ROE

25.77%

P/VP

5.12

PFE - Pfizer

$27.49 22,43% (12 M)

P/L

35.85

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Amarin Corporation (AMRN) today?

A cotação de Amarin Corporation (AMRN) hoje está em US$ 13.68, com uma variação de -10.91% em relação ao último ano. A cotação de Amarin Corporation (AMRN) iniciou o ano negociando na casa dos US$ 13.96 e hoje está em US$ 13.68. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Amarin Corporation (AMRN) e dados de ações do Ibovespa e mercados internacionais.

Quando Amarin Corporation (AMRN) paga dividendos?

Amarin Corporation (AMRN) não distribuiu dividendos no último ano.

Is Amarin Corporation (AMRN) a good investment?

Atualmente, Amarin Corporation (AMRN) está cotada a US$ 13.68, com um P/L de -209.96, representando um desvio de -12,321% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de -10.91 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de -10.91%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Amarin Corporation (AMRN) stock?

Investir em ações de Amarin Corporation (AMRN) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Amarin Corporation (AMRN) yield today?

A rentabilidade de Amarin Corporation (AMRN) foi de -3.87% no último mês, -10.91% no último ano e -86.67% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Amarin Corporation (AMRN) hoje, o investimento total seria de US$ 1,367.50, com base na cotação atual de US$ 13.68.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 1,218.31
Em 5 anos: US$ 182.29
Em 10 anos: US$ 346.25

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

AMRN

Amarin Corporation PLC

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment AMRN

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING AMRN WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Amarin Corporation

Amarin Corporation PLC

United States

37 years

1993

1.000

PROFIT X PRICE AMRN

Financial Results AMRN

AMRN cash flow

Asset, Revenue and Profit Growth - AMRN

AMRN balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions